Subgroup analysis from JAVELIN Renal 101: Outcomes for avelumab plus axitinib (A + Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Choueiri, T. K.; Motzer, R. J.; Campbell, M. T.; Alekseev, B. Y.; Uemura, M.; Kollmannsberger, C. K.; Gravis, G.; Bjarnason, G. A.; Gurney, H.; Chung, J.; Haanen, J. B. A. G.; Rini, B. I.; Larkin, J. M. G.; Schmidinger, M.; Nole, F.; Chudnovsky, A.; Huang, B.; Hariharan, S.; di Pietro, A.; Albiges, L. |
| Abstract Title: | Subgroup analysis from JAVELIN Renal 101: Outcomes for avelumab plus axitinib (A + Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 2019 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2019 Feb 14-16 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-01 |
| Language: | English |
| ACCESSION: | WOS:000489108800545 |
| DOI: | 10.1200/JCO.2019.37.7_suppl.544 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 544 -- Source: Wos |
